Camilla Dalby Hansen

Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease

Maria Kjærgaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge et al. · Journal of Hepatology · 2023 · 178 citations · Full text

Epidemiology, Hepatology, Nonalcoholic Fatty Liver Disease +12

Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis

Han Gao, Matt C. Danzi, Claire Choi et al. · Cell Reports · 2017 · 137 citations · Full text

Macrophagic Tnfr2, Tnf Receptor 2, Immunology +18

Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study

Mads Israelsen, Nikolaj Torp, Stine Johansen et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 131 citations · Full text

Excessive Alcohol Intake, Substance Abuse, Metabolic Associated Steatohepatitis +14

Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Camilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen et al. · Annals of Internal Medicine · 2022 · 98 citations

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

Mads Israelsen, Bjørn Stæhr Madsen, Nikolaj Torp et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 70 citations · Full text